DAYSI ABREU: Open Payments
NPI 1285119172 · RIVERVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,587 in 130 payments from 19 companies in 2025. Trend: 2023 $2,099 · 2024 $2,362 · 2025 $2,587
Food & beverage: $2,408Education: $179
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $355 |
| Galderma Laboratories, L.P. | 26 | $310 |
| Janssen Biotech, Inc. | 16 | $305 |
| ABBVIE INC. | 13 | $220 |
| Regeneron Healthcare Solutions, Inc. | 9 | $220 |
| GENZYME CORPORATION | 6 | $162 |
| Arcutis Biotherapeutics, Inc. | 11 | $140 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $137 |
| LEO Pharma Inc. | 5 | $133 |
| PFIZER INC. | 6 | $126 |
Products named: DUPIXENT, Bimzelx, NEMLUVIO, TREMFYA, SKYRIZI, Zoryve, CIBINQO, ADBRY.
Industry payments across FL — which companies pay providers there.
